The anti-cancer effects of ASA are primarily attributed to its ability to inhibit cyclooxygenase 2 (COX2) activity, which is often up-regulated in breast cancer [11, 12], and reduce production of prostaglandin E2 (PGE2), the predominant secreted prostaglandin in breast tumors [13]. The gene discussed is PTGS2; the disease is breast neoplasm.